RENSANSE Trademark

Trademark Overview


On Thursday, January 19, 2023, a trademark application was filed for RENSANSE with the United States Patent and Trademark Office. The USPTO has given the RENSANSE trademark a serial number of 97761623. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, January 23, 2024. This trademark is owned by MAPS Public Benefit Corporation. The RENSANSE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, prescription psychotropic drugs; Psychotherapeutic preparations for managing and treating mental illnesses and psychiatric, psychological, and neurological disorders and conditions affecting mood, thought, behavior, and perception; Pharmaceutical preparations for the treatment and management of psychiatric, psychological, and neurological disorders; Therapeutic agents for treating and managing PTSD, eating disorders, postpartum depression, alcohol use disorder, opioid and substance use disorder, generalized anxiety disorder, social anxiety disorder, major depressive disorder, and traumatic brain injury; Medicaments to help assist with treatment and management of psychiatric, psychological, and neurological disorders
rensanse

General Information


Serial Number97761623
Word MarkRENSANSE
Filing DateThursday, January 19, 2023
Status688 - NOTICE OF ALLOWANCE - ISSUED
Status DateTuesday, January 23, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 28, 2023

Trademark Statements


Goods and ServicesPharmaceutical preparations, namely, prescription psychotropic drugs; Psychotherapeutic preparations for managing and treating mental illnesses and psychiatric, psychological, and neurological disorders and conditions affecting mood, thought, behavior, and perception; Pharmaceutical preparations for the treatment and management of psychiatric, psychological, and neurological disorders; Therapeutic agents for treating and managing PTSD, eating disorders, postpartum depression, alcohol use disorder, opioid and substance use disorder, generalized anxiety disorder, social anxiety disorder, major depressive disorder, and traumatic brain injury; Medicaments to help assist with treatment and management of psychiatric, psychological, and neurological disorders

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, January 25, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameLYKOS THERAPEUTICS, INC.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressBOSTON, MA 02111

Party NameMAPS Public Benefit Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBoston, MA 02111

Party NameMAPS Public Benefit Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBoston, MA 02111

Trademark Events


Event DateEvent Description
Wednesday, April 3, 2024AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, January 23, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 28, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 28, 2023PUBLISHED FOR OPPOSITION
Wednesday, November 8, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, October 25, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 25, 2023EXAMINER'S AMENDMENT ENTERED
Wednesday, October 25, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, October 25, 2023EXAMINERS AMENDMENT E-MAILED
Wednesday, October 25, 2023EXAMINERS AMENDMENT -WRITTEN
Tuesday, October 24, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, October 24, 2023NON-FINAL ACTION E-MAILED
Tuesday, October 24, 2023NON-FINAL ACTION WRITTEN
Tuesday, October 17, 2023ASSIGNED TO EXAMINER
Wednesday, January 25, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, January 23, 2023NEW APPLICATION ENTERED